American Health Council Names Guo-Ping Shi MSc, DSc to Education Board

NEW YORK, Nov. 22, 2016 -- Dr. Guo-Ping Shi, Biochemist at Brigham and Women’s Hospital and Associate Professor of Harvard Medical School, has been selected to join the Education Board at the American Health Council. He will be sharing his knowledge and expertise in the areas of Cardiovascular Medicine and Metabolism.

Dr. Guo-Ping Shi, Biochemist at Brigham and Women’s Hospital and Associate Professor of Harvard Medical School, has been selected to join the Education Board at the American Health Council.

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/fcc55fff-9677-4bd0-9c28-e30b57070c16

Dr. Shi has been active in the healthcare industry for the last 27 years. He received his DSc in Environmental Health from Harvard University in 1995. A desire to contribute to the community, make a difference in the field of healthcare, and help cure diseases led him to become a medical professional with focuses on Cardiovascular Medicine and Metabolic Diseases. Dr. Shi’s day-to-day responsibilities include research, public speaking, conferences, seminars, presentations, and teaching.

Boston’s Brigham and Women’s Hospital, a major teaching hospital of Harvard Medical School, is an international leader in many areas of medicine with its focuses on patient care and medical research. Dr. Shi’s contributions to the global scientific community include leadership in the fields of cysteine protease cathepsins and mast cells in the pathogenesis of cardiovascular, metabolic, neurological, autoimmune, and renal diseases.

Dr. Shi is proud to be internationally recognized in the field of mast cell (MC) functions in cardiovascular and metabolic diseases and to have led the demonstration of direct participation of MCs in atherosclerosis, diabetes, obesity, and abdominal aortic aneurysms. Using experimental models, his group has been involved in demonstrating that MCs release pro-inflammatory cytokines to activate inflammatory cells and vascular cells. Pharmacological inactivation of MCs reduces or prevents tissue inflammation and disease progression. The group’s series of articles in highly ranked seminal publications, including Nature Medicine, The Journal of Clinical Investigation, and Circulation, have broadened the fields of basic and clinical researches regarding MCs, which have already shown benefits among patients. These studies have yielded the group 4 R01s and an AHA Established Investigator Award, along with 2 patents, 4 invited local presentations, 4 nationally invited presentations, 40 internationally invited presentations, 16 media interviews, at least 3 television and satellite news reports, and more than 150 online news reports. Recent studies in MCs focus on their functions in Alzheimer’s disease and SLE. Preliminary studies have already yielded an NIH R01 application.

Dr. Shi is very proud of his discoveries in basic and clinical research and finds it very rewarding to be able to make a difference in cardiovascular medicine and metabolism. He attributes his success to his strong work ethic. Dr. Shi has published over 170 medical articles, as well as 4 book chapters, throughout a wide variety of highly ranked clinical and basic research journals. He has received the Established Investigator Award from the American Heart Association, the Award for Outstanding Research Achievement from the Nature Publishing Group, and many others. His researches have been funded continuously without interruption by the NIH Research Project grants (R01s) for the past 20 years. Dr. Shi is a member of the American Heart Association, American Diabetes Association, and American Association of Immunologists.

In his spare time, Dr. Shi enjoys fishing.

For more information, please contact:
Elizabeth Moore
American Health Council
Hauppauge, NY United States
Phone: 1-212-390-0214
Email: [email protected]